Results 11 to 20 of about 6,798 (212)

Design and evaluation of a peptide‐based immunotoxin for breast cancer therapeutics

open access: yesFEBS Open Bio, 2015
Immunotoxins are chimeric proteins comprising a specific cellular targeting domain linked to a cytotoxic factor. Here we describe the design and use of a novel, peptide‐based immunotoxin that can initiate selective cytotoxicity on ErbB2‐positive cells ...
Kelsey J. Weigel   +6 more
doaj   +2 more sources

Deltex 2 Mediates Oxidative Stress and Neurotoxicity in Freezing of Gait of Parkinson's Disease via the Notch2‐Nrf2 Axis [PDF]

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Under normal conditions, Notch2 promotes Nrf2 transcription by forming a transcriptional activation complex, which is crucial for maintaining the antioxidant capacity of human dopamine‐like neural cells. In pathological conditions, increased DTX2 expression has been shown to mediate Notch2 ubiquitination and subsequent degradation, leading to reduced ...
Qibin Zheng   +7 more
wiley   +2 more sources

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM [PDF]

open access: yesMediators of Inflammation, 2015
Epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein overexpressed in human epithelioma but with relatively low expression in normal epithelial tissues.
Minghua Lv   +9 more
doaj   +2 more sources

Comparison of two immunotoxins against DLL3 receptor; as an inhibitor for small cell lung cancer [PDF]

open access: yesFrontiers in Molecular Biosciences
Despite the efforts of researchers to develop new treatments for small cell lung cancer (SCLC), achieving effective treatment has not yet happened. Targeted therapy utilizing delta-like ligand 3 (DLL3), which is highly expressed in SCLC patients, holds ...
Mohammad Hossein Ataee   +4 more
doaj   +2 more sources

Integrated bioprocessing and genetic strategies to enhance soluble expression of anti-HER2 immunotoxin in E. Coli [PDF]

open access: yesAMB Express
Immunotoxins are widely applied for cancer therapy. However, bacterial expression of immunotoxins usually leads to the formation of insoluble and non-functional recombinant proteins. This study was aimed to improve soluble expression of a novel anti-HER2
Sheida Mani   +3 more
doaj   +2 more sources

Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV. [PDF]

open access: yesJCI Insight
Antibody-mediated depletion studies have demonstrated that CD8+ T cells are required for effective immune control of SIV. However, this approach is potentially confounded by several factors, including reactive CD4+ T cell proliferation, and provides no ...
Simpson J   +10 more
europepmc   +2 more sources

Cloning and Expression of Recombinant Immunotoxin using Diphtheria Toxin and Granulocyte Colony Stimulating Factor (G-CSF) [PDF]

open access: yesMajallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2016
Background: Immunotoxin (IT) is a directed toxin containing two distinct sections (immune and toxin parts) covalently bond using specific chemical or peptide linkers.
Fatemeh Donyapoor   +2 more
doaj   +1 more source

A Novel Immunotoxin Based on BmK AGAP Toxin for HER2-Positive Breast Cancer: An In Silico Study [PDF]

open access: yesJournal of Mazandaran University of Medical Sciences
Background and purpose: Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. The HER2 protein, an epidermal growth factor receptor, is overexpressed in approximately 25% of breast cancer cases, making it a key ...
Sadaf Azdoo   +12 more
doaj   +1 more source

Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins [PDF]

open access: yesToxins
Protein toxins are biologically active polypeptides produced by a variety of organisms, including bacteria, plants, fungi, and animals. These molecules exert potent and specific toxic effects on target cells and are primarily associated with ...
Richa Misra   +6 more
doaj   +2 more sources

Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy [PDF]

open access: yesFrontiers in Microbiology
Immunotoxins (ITs), as targeted cancer therapies, confront limitations including off-target effects, immunogenicity, and inadequate tumor penetration, hindering clinical translation.
Quan Wang   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy